Go Pro
Cantor Fitzgerald

Cantor Fitzgerald Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Cantor Fitzgerald. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Cantor Fitzgerald's equity research team. MarketBeat is not affiliated with or endorsed by Cantor Fitzgerald.

Average Return
00.00% 12-Month ROI
Total Ratings
1,881 Last 12 Months
Buy Ratings
1,326 Last 12 Months
Sell Ratings
14 Last 12 Months
Companies Covered
587 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
$1.90
+5.8%
9/28/2026Initiated Coverage$8.00OverweightView details for Cantor Fitzgerald rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 9/28/2026
Paychex, Inc. stock logo
PAYX
Paychex
$99.30
-2.0%
9/28/2026Lower Price Target$112.00 ➝ $96.00UnderweightView details for Cantor Fitzgerald rating of Paychex (NASDAQ:PAYX) on 9/28/2026
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$230.05
+2.0%
9/25/2026Reiterated Rating$300.00OverweightView details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/25/2026
Porch Group, Inc. stock logo
PRCH
Porch Group
$16.83
+1.8%
9/25/2026Boost Price Target$18.00 ➝ $20.00OverweightView details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 9/25/2026
Block, Inc. stock logo
XYZ
Block
$73.32
-4.1%
9/25/2026Reiterated Rating$95.00OverweightView details for Cantor Fitzgerald rating of Block (NYSE:XYZ) on 9/25/2026
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$14.46
+4.4%
9/24/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/24/2026
Arthur J. Gallagher & Co. stock logo
AJG
Arthur J. Gallagher & Co.
$228.95
-0.9%
9/24/2026Reiterated RatingNeutralView details for Cantor Fitzgerald rating of Arthur J. Gallagher & Co. (NYSE:AJG) on 9/24/2026
Mesoblast Limited stock logo
MESO
Mesoblast
$14.50
-4.1%
9/24/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 9/24/2026
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$36.98
+3.3%
9/24/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 9/24/2026
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$266.70
-1.8%
9/24/2026Reiterated Rating$476.00OverweightView details for Cantor Fitzgerald rating of Dycom Industries (NYSE:DY) on 9/24/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$1.11
-1.8%
9/23/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026
ENHA
Enhanced Group
$1.55
+7.3%
9/23/2026Initiated Coverage$4.00OverweightView details for Cantor Fitzgerald rating of Enhanced Group (NYSE:ENHA) on 9/23/2026
Elastic N.V. stock logo
ESTC
Elastic
$88.21
+0.1%
9/23/2026Reiterated Rating$100.00NeutralView details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 9/23/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$715.62
-4.8%
9/23/2026Boost Price Target$680.00 ➝ $860.00OverweightView details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 9/23/2026
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$38.22
+4.2%
9/22/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 9/22/2026
FormFactor, Inc. stock logo
FORM
FormFactor
$130.97
+1.0%
9/22/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of FormFactor (NASDAQ:FORM) on 9/22/2026
Camtek Ltd. stock logo
CAMT
Camtek
$142.61
-3.0%
9/22/2026Reiterated Rating$175.00NeutralView details for Cantor Fitzgerald rating of Camtek (NASDAQ:CAMT) on 9/22/2026
Advanced Energy Industries, Inc. stock logo
AEIS
Advanced Energy Industries
$277.84
-0.7%
9/22/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Advanced Energy Industries (NASDAQ:AEIS) on 9/22/2026
AvePoint, Inc. stock logo
AVPT
AvePoint
$13.67
+5.2%
9/22/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 9/22/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$15.48
-0.8%
9/22/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 9/22/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$29.30
+3.0%
9/22/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of ArriVent BioPharma (NASDAQ:AVBP) on 9/22/2026
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$50.80
-0.4%
9/22/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of AnaptysBio (NASDAQ:ANAB) on 9/22/2026
Lipocine Inc. stock logo
LPCN
Lipocine
$2.09
-0.5%
9/22/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Lipocine (NASDAQ:LPCN) on 9/22/2026
Entera Bio Ltd. stock logo
ENTX
Entera Bio
$2.69
-1.8%
9/22/2026Initiated CoverageOverweightView details for Cantor Fitzgerald rating of Entera Bio (NASDAQ:ENTX) on 9/22/2026
Omeros Corporation stock logo
OMER
Omeros
$19.43
-3.2%
9/22/2026Upgrade$22.00Neutral ➝ OverweightView details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 9/22/2026
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$31.49
+1.3%
9/22/2026Boost Price Target$61.00 ➝ $72.00OverweightView details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/22/2026
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
$65.95
+5.2%
9/22/2026Boost Price Target$130.00 ➝ $137.00OverweightView details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 9/22/2026
eToro Group Ltd. stock logo
ETOR
eToro Group
$25.82
-2.2%
9/21/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of eToro Group (NASDAQ:ETOR) on 9/21/2026
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
$6.11
-3.4%
9/21/2026 Reiterated RatingNeutralView details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 9/21/2026
Satellogic Inc. stock logo
SATL
Satellogic
$6.05
-1.9%
9/21/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Satellogic (NASDAQ:SATL) on 9/21/2026
Intuitive Machines, Inc. stock logo
LUNR
Intuitive Machines
$15.20
-2.6%
9/21/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 9/21/2026
Aurora Innovation, Inc. stock logo
AUR
Aurora Innovation
$5.29
-12.4%
9/21/2026Reiterated Rating$12.00OverweightView details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 9/21/2026
Lucid Group, Inc. stock logo
LCID
Lucid Group
$3.90
-4.2%
9/21/2026Reiterated RatingNeutralView details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 9/21/2026
Rocket Lab Corporation stock logo
RKLB
Rocket Lab
$72.19
-2.4%
9/21/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Rocket Lab (NASDAQ:RKLB) on 9/21/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.13
+1.0%
9/21/2026 Reiterated Rating$70.00NeutralView details for Cantor Fitzgerald rating of Scholar Rock (NASDAQ:SRRK) on 9/21/2026
Five9, Inc. stock logo
FIVN
Five9
$34.66
-3.1%
9/21/2026Boost Price Target$34.00 ➝ $40.00OverweightView details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 9/21/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$509.22
-1.3%
9/21/2026Boost Price Target$522.00 ➝ $608.00OverweightView details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 9/21/2026
ServiceNow, Inc. stock logo
NOW
ServiceNow
$131.27
-3.2%
9/21/2026Boost Price Target$141.00 ➝ $174.00OverweightView details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 9/21/2026
Securitize Holdings stock logo
SECZ
Securitize
$16.63
+4.2%
9/21/2026Initiated Coverage$21.20OverweightView details for Cantor Fitzgerald rating of Securitize (NYSE:SECZ) on 9/21/2026
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$178.54
-4.9%
9/21/2026Boost Price Target$175.00 ➝ $220.00OverweightView details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 9/21/2026
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)

James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel

Watch James Altucher's free masterclass before December 8th
Global Medical REIT Inc. stock logo
XRN
Global Medical REIT
$35.52
-0.9%
9/21/2026Initiated Coverage$43.00OverweightView details for Cantor Fitzgerald rating of Global Medical REIT (NYSE:XRN) on 9/21/2026
Evommune, Inc. stock logo
EVMN
Evommune
$8.38
-1.4%
9/18/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Evommune (NYSE:EVMN) on 9/18/2026
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$5.29
-2.0%
9/18/2026Boost Price Target$28.00 ➝ $30.00OverweightView details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 9/18/2026
HubSpot, Inc. stock logo
HUBS
HubSpot
$203.50
-4.8%
9/18/2026Reiterated Rating$200.00NeutralView details for Cantor Fitzgerald rating of HubSpot (NYSE:HUBS) on 9/18/2026
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
$14.41
-0.6%
9/18/2026Boost Price Target$33.00 ➝ $39.00OverweightView details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/18/2026
Upexi, Inc. stock logo
UPXI
Upexi
$1.19
-3.3%
9/18/2026Reiterated Rating$2.00OverweightView details for Cantor Fitzgerald rating of Upexi (NASDAQ:UPXI) on 9/18/2026
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
$2.30
+2.7%
9/17/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 9/17/2026
Salesforce Inc. stock logo
CRM
Salesforce
$227.17
-2.9%
9/17/2026Reiterated Rating$300.00OverweightView details for Cantor Fitzgerald rating of Salesforce (NYSE:CRM) on 9/17/2026
onsemi stock logo
ON
onsemi
$75.65
-2.0%
9/17/2026Lower Price Target$110.00 ➝ $90.00NeutralView details for Cantor Fitzgerald rating of onsemi (NASDAQ:ON) on 9/17/2026
Generac Holdings Inc. stock logo
GNRC
Generac
$205.03
-1.5%
9/16/2026Reiterated Rating$333.00OverweightView details for Cantor Fitzgerald rating of Generac (NYSE:GNRC) on 9/16/2026
Alumis Inc. stock logo
ALMS
Alumis
$7.16
+0.8%
9/16/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 9/16/2026
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
$11.87
+2.2%
9/16/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 9/16/2026
AbbVie Inc. stock logo
ABBV
AbbVie
$266.39
+0.8%
9/16/2026Reiterated Rating$250.00 ➝ $240.00OverweightView details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 9/16/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$15.08
-2.5%
9/16/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Avalo Therapeutics (NASDAQ:AVTX) on 9/16/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
$11.56
-4.0%
9/16/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/16/2026
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
$9.23
+5.2%
9/16/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Q32 Bio (NASDAQ:QTTB) on 9/16/2026
Ulta Beauty Inc. stock logo
ULTA
Ulta Beauty
$549.13
+0.7%
9/15/2026 Initiated CoverageOverweightView details for Cantor Fitzgerald rating of Ulta Beauty (NASDAQ:ULTA) on 9/15/2026
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$4.68
+0.2%
9/15/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of MiMedx Group (NASDAQ:MDXG) on 9/15/2026
Nyxoah SA stock logo
NYXH
Nyxoah
$1.59
+9.7%
9/15/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Nyxoah (NASDAQ:NYXH) on 9/15/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$14.15
+0.6%
9/15/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 9/15/2026
Robinhood Markets, Inc. stock logo
HOOD
Robinhood Markets
$116.46
-2.5%
9/15/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Robinhood Markets (NASDAQ:HOOD) on 9/15/2026
Procore Technologies, Inc. stock logo
PCOR
Procore Technologies
$49.14
-0.3%
9/15/2026Initiated Coverage$65.00OverweightView details for Cantor Fitzgerald rating of Procore Technologies (NYSE:PCOR) on 9/15/2026
Bentley Systems, Incorporated stock logo
BSY
Bentley Systems
$31.29
-0.5%
9/14/2026Initiated Coverage$37.00OverweightView details for Cantor Fitzgerald rating of Bentley Systems (NASDAQ:BSY) on 9/14/2026
Samsara Inc. stock logo
IOT
Samsara
$37.97
+0.0%
9/14/2026Initiated Coverage$45.00OverweightView details for Cantor Fitzgerald rating of Samsara (NYSE:IOT) on 9/14/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$207.19
-1.1%
9/14/2026Initiated Coverage$215.00NeutralView details for Cantor Fitzgerald rating of Autodesk (NASDAQ:ADSK) on 9/14/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$31.91
-0.3%
9/14/2026Reiterated Rating$65.00OverweightView details for Cantor Fitzgerald rating of Pharvaris (NASDAQ:PHVS) on 9/14/2026
ASML Holding N.V. stock logo
ASML
ASML
$1,771.41
+1.6%
9/14/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of ASML (NASDAQ:ASML) on 9/14/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$207.19
-1.1%
9/14/2026UpgradeHoldView details for Cantor Fitzgerald rating of Autodesk (NASDAQ:ADSK) on 9/14/2026
Bentley Systems, Incorporated stock logo
BSY
Bentley Systems
$31.29
-0.5%
9/14/2026UpgradeStrong-BuyView details for Cantor Fitzgerald rating of Bentley Systems (NASDAQ:BSY) on 9/14/2026
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$14.56
+0.6%
9/14/2026Upgrade$20.00Neutral ➝ OverweightView details for Cantor Fitzgerald rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/14/2026
Samsara Inc. stock logo
IOT
Samsara
$37.97
+0.0%
9/14/2026UpgradeStrong-BuyView details for Cantor Fitzgerald rating of Samsara (NYSE:IOT) on 9/14/2026
Procore Technologies, Inc. stock logo
PCOR
Procore Technologies
$49.14
-0.3%
9/14/2026UpgradeStrong-BuyView details for Cantor Fitzgerald rating of Procore Technologies (NYSE:PCOR) on 9/14/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$715.62
-4.8%
9/11/2026Reiterated RatingNeutralView details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 9/11/2026
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$66.16
+2.3%
9/11/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 9/11/2026
Incyte Corporation stock logo
INCY
Incyte
$124.82
+0.8%
9/11/2026 Reiterated RatingNeutralView details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 9/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
$87.90
-1.4%
9/11/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 9/11/2026
Centene Corporation stock logo
CNC
Centene
$62.45
+1.0%
9/11/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 9/11/2026
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
$25.03
+0.2%
9/11/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Arcus Biosciences (NYSE:RCUS) on 9/11/2026
MannKind Corporation stock logo
MNKD
MannKind
$3.35
+0.3%
9/11/2026Reiterated Rating$8.00OverweightView details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 9/11/2026
Oracle Corporation stock logo
ORCL
Oracle
$132.64
-3.3%
9/11/2026Reiterated Rating$229.00 ➝ $284.00OverweightView details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 9/11/2026
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
$11.64
+0.7%
9/10/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of DBV Technologies (NASDAQ:DBVT) on 9/10/2026
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
$4.75
+1.5%
9/10/2026 Reiterated Rating$11.00OverweightView details for Cantor Fitzgerald rating of Aquestive Therapeutics (NASDAQ:AQST) on 9/10/2026
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
$18.80
-2.1%
9/10/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 9/10/2026
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$21.45
-1.4%
9/10/2026 Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.85
+2.2%
9/10/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Tenax Therapeutics (NASDAQ:TENX) on 9/10/2026
SUIG
Sui Group
$1.60
+0.6%
9/10/2026Boost Price Target$1.70 ➝ $3.40OverweightView details for Cantor Fitzgerald rating of Sui Group (NASDAQ:SUIG) on 9/10/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.91
-3.2%
9/10/2026Reiterated Rating$7.10 ➝ $11.20OverweightView details for Cantor Fitzgerald rating of Hyperion DeFi (NASDAQ:HYPD) on 9/10/2026
Forward Industries, Inc. stock logo
FWDI
Forward Industries
$8.05
-4.4%
9/10/2026Boost Price Target$8.00 ➝ $16.00OverweightView details for Cantor Fitzgerald rating of Forward Industries (NASDAQ:FWDI) on 9/10/2026
DeFi Development Corp. stock logo
DFDV
DeFi Development
$5.57
-7.8%
9/10/2026Reiterated Rating$4.70 ➝ $10.40OverweightView details for Cantor Fitzgerald rating of DeFi Development (NASDAQ:DFDV) on 9/10/2026
BitMine Immersion Technologies, Inc. stock logo
BMNR
BitMine Immersion Technologies
$26.83
-2.7%
9/10/2026Boost Price Target$30.60 ➝ $63.60OverweightView details for Cantor Fitzgerald rating of BitMine Immersion Technologies (NYSE:BMNR) on 9/10/2026
Should You Convert a Traditional IRA to a Roth After 60? (Ad)

Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-free qualified withdrawals, and no lifetime required minimum distributions. The catch: converting triggers ordinary income tax in the year you convert, and the decision cannot be reversed. The right move depends on your income, tax bracket, and retirement timeline.tc pixel

Take the free quiz to match with a vetted fiduciary advisor near you
Centerspace stock logo
CSR
Centerspace
$55.59
+0.5%
9/10/2026Reiterated Rating$57.00NeutralView details for Cantor Fitzgerald rating of Centerspace (NYSE:CSR) on 9/10/2026
Cypherpunk Technologies stock logo
CYPH
Cypherpunk Technologies
$3.31
-19.7%
9/10/2026Boost Price Target$1.60 ➝ $4.90OverweightView details for Cantor Fitzgerald rating of Cypherpunk Technologies (NASDAQ:CYPH) on 9/10/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
$12.08
-6.0%
9/10/2026Boost Price Target$22.60 ➝ $34.20OverweightView details for Cantor Fitzgerald rating of Hyperliquid Strategies (NASDAQ:PURR) on 9/10/2026
Sharplink Gaming Inc. stock logo
SBET
Sharplink Gaming
$9.50
-1.3%
9/10/2026Boost Price Target$8.30 ➝ $17.00OverweightView details for Cantor Fitzgerald rating of Sharplink Gaming (NASDAQ:SBET) on 9/10/2026
Upexi, Inc. stock logo
UPXI
Upexi
$1.19
-3.3%
9/10/2026Boost Price Target$1.30 ➝ $2.00OverweightView details for Cantor Fitzgerald rating of Upexi (NASDAQ:UPXI) on 9/10/2026
Braze, Inc. stock logo
BRZE
Braze
$23.17
-4.9%
9/9/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Braze (NASDAQ:BRZE) on 9/9/2026
Texas Instruments Incorporated stock logo
TXN
Texas Instruments
$278.31
+0.1%
9/9/2026Reiterated RatingNeutralView details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 9/9/2026
onsemi stock logo
ON
onsemi
$75.65
-2.0%
9/9/2026Reiterated RatingNeutralView details for Cantor Fitzgerald rating of onsemi (NASDAQ:ON) on 9/9/2026
Microchip Technology Incorporated stock logo
MCHP
Microchip Technology
$77.97
-0.9%
9/9/2026Reiterated RatingOverweightView details for Cantor Fitzgerald rating of Microchip Technology (NASDAQ:MCHP) on 9/9/2026
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$9.94
+7.6%
9/9/2026Initiated Coverage$10.71OverweightView details for Cantor Fitzgerald rating of Sagimet Biosciences (NASDAQ:SGMT) on 9/9/2026

MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms in the last 90 days. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Cantor Fitzgerald's equity research team has issued ratings on 580 companies across 11 sectors over the past 12 months, covered by 50 analysts. The Cantor Fitzgerald analysts below are listed by number of ratings issued in the last year.

Cantor Fitzgerald Stock Coverage by Sector

Cantor Fitzgerald concentrates its research most heavily in Healthcare (34.2%), Technology (21.8%) and Finance (12.3%). The chart below shows how Cantor Fitzgerald's 587 rated companies are distributed across all 11 sectors it covers.

Cantor Fitzgerald - Frequently Asked Questions

Cantor Fitzgerald's analysts currently have buy-equivalent ratings on 464 companies. Recent upgrades to buy include Omeros, Bentley Systems, 4D Molecular Therapeutics, Procore Technologies and Samsara.

Cantor Fitzgerald's highest-rated analysts by MarketBeat's accuracy score include Eric Schmidt, Matthew Prisco and Kristen Kluska. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 50 analysts at Cantor Fitzgerald.

Cantor Fitzgerald has the deepest coverage in Healthcare (34.2% of rated companies), Technology (21.8% of rated companies), Finance (12.3% of rated companies), Industrials (10.7% of rated companies) and Real Estate (8.7% of rated companies).

Cantor Fitzgerald issued 1,881 ratings over the last 12 months across 587 companies — an average of roughly 157 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Cantor Fitzgerald analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Cantor Fitzgerald uses Buy, Hold, and Sell as their equivalents.